Clinical Diagnostics in Patients with Cerebral Infarction Due To Covid-19
Keywords:Diagnostics, Cerebral infarction, Corona Virus Disease 19 (COVID-19)
The Corona Virus Disease 19 (COVID-19) outbreak is a deadly disease of concern to the world, including
Indonesia. Reported cases of death show a high number with more than 3800 deaths reported. This disease
can induce Cytokine Storm Syndrome (CSS) and interfere with the Blood-Brain Barrier (BBB), causing
coagulopathy and hypoxia, which in turn lead to cerebral edema in the brain. This research uses a case
study approach, with a detailed examination of one event. In this case, cerebral infarction was caused by
COVID-19 as evidenced by laboratory results in the presence of symptoms of inflammation, CSF, sepsis,
and coagulopathy. These symptoms can result in cerebral infarction and hypercoagulability. therapeutic
interventions are carried out in reducing inflammation, reducing cerebral edema, and preventing secondary
infection. COVID-19 in this case can have a deleterious effect on patients with cerebral infarction. Proper
treatment is needed to give better results.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details
This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions